CL2013002210A1 - Formulación prebiótica para consumo humano que comprende 2´-fucosilactosa, 3´-sialilactosa y 6´-sialilactosa, en que la cantidad en peso de 3´-sialilactosa es al menos igual de elevada que la cantidad de 2´-fucosilactosa; y método para modular o estimular la proliferación de bifidobacterias en el intestino humano. - Google Patents
Formulación prebiótica para consumo humano que comprende 2´-fucosilactosa, 3´-sialilactosa y 6´-sialilactosa, en que la cantidad en peso de 3´-sialilactosa es al menos igual de elevada que la cantidad de 2´-fucosilactosa; y método para modular o estimular la proliferación de bifidobacterias en el intestino humano.Info
- Publication number
- CL2013002210A1 CL2013002210A1 CL2013002210A CL2013002210A CL2013002210A1 CL 2013002210 A1 CL2013002210 A1 CL 2013002210A1 CL 2013002210 A CL2013002210 A CL 2013002210A CL 2013002210 A CL2013002210 A CL 2013002210A CL 2013002210 A1 CL2013002210 A1 CL 2013002210A1
- Authority
- CL
- Chile
- Prior art keywords
- sialylactose
- fucosylactose
- amount
- human
- bifidobacteria
- Prior art date
Links
- 241000186000 Bifidobacterium Species 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 210000000936 intestine Anatomy 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 235000013406 prebiotics Nutrition 0.000 title 1
- 230000035755 proliferation Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pediatric Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dairy Products (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161441451P | 2011-02-10 | 2011-02-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2013002210A1 true CL2013002210A1 (es) | 2014-01-10 |
Family
ID=45809349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2013002210A CL2013002210A1 (es) | 2011-02-10 | 2013-08-01 | Formulación prebiótica para consumo humano que comprende 2´-fucosilactosa, 3´-sialilactosa y 6´-sialilactosa, en que la cantidad en peso de 3´-sialilactosa es al menos igual de elevada que la cantidad de 2´-fucosilactosa; y método para modular o estimular la proliferación de bifidobacterias en el intestino humano. |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US20140371173A1 (es) |
| EP (2) | EP2672844B2 (es) |
| CN (2) | CN103347405A (es) |
| AU (1) | AU2012215042B2 (es) |
| BR (1) | BR112013020108A2 (es) |
| CA (1) | CA2825697A1 (es) |
| CL (1) | CL2013002210A1 (es) |
| ES (2) | ES2692533T3 (es) |
| IL (1) | IL227487A (es) |
| MX (2) | MX362129B (es) |
| MY (1) | MY161034A (es) |
| PL (1) | PL2672844T3 (es) |
| PT (1) | PT2672844E (es) |
| RU (1) | RU2586928C2 (es) |
| SG (1) | SG192095A1 (es) |
| TW (1) | TW201244640A (es) |
| WO (1) | WO2012107865A2 (es) |
| ZA (1) | ZA201306751B (es) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112013020108A2 (pt) | 2011-02-10 | 2017-06-13 | Nestec Sa | modulação do crescimento de bifidobactérias usando uma combinação de oligossacarídeos encontrados no leite de ser humano |
| CN103997899B (zh) | 2011-06-20 | 2016-04-20 | H.J.亨氏公司 | 益生菌组合物和方法 |
| CN104507483A (zh) * | 2012-04-13 | 2015-04-08 | 波士顿学院理事会 | 益生元组合物及使用方法 |
| ES2572831T3 (es) | 2012-09-14 | 2016-06-02 | Abbott Laboratories | Composiciones nutricionales para su uso en métodos para modular los niveles de corticosterona en individuos con estrés psicológico |
| EP3673909A1 (en) | 2014-04-08 | 2020-07-01 | Abbott Laboratories | Nutritional compositions for use in treating enteric infection comprising human milk oligosaccharides |
| CA2965663C (en) * | 2014-10-24 | 2023-04-04 | Evolve Biosystems, Inc. | Activated bifidobacteria and methods of use thereof |
| EP3223825A1 (en) * | 2014-11-26 | 2017-10-04 | Abbott Laboratories | Infant formula comprising human milk oligosaccharides, polyunsaturated fatty acids, nucleotides, and lutein |
| US20170354696A1 (en) * | 2014-11-26 | 2017-12-14 | Abbott Laboratories | Infant formula with rrr-alpha-tocopherol, 2'-fucosyllactose, and a probiotic |
| US10987368B2 (en) | 2014-12-08 | 2021-04-27 | Glycom A/S | Synthetic composition for preventing or treating CVD |
| US10881674B2 (en) | 2014-12-08 | 2021-01-05 | Glycom A/S | Synthetic composition for treating metabolic disorders |
| CN107106584A (zh) | 2014-12-08 | 2017-08-29 | 格礼卡姆股份公司 | 用于治疗代谢障碍的合成组合物 |
| US10835544B2 (en) | 2014-12-08 | 2020-11-17 | Glycom A/S | Synthetic composition for regulating satiety |
| WO2016139330A1 (en) * | 2015-03-05 | 2016-09-09 | Nestec S.A. | Compositions for use in improving stool consistency or frequency in infants or young children |
| ES2950489T3 (es) * | 2015-10-28 | 2023-10-10 | Glycom As | Composición sintética y método para modular los trastornos de la emoción y del ánimo |
| ES2927009T3 (es) | 2015-10-28 | 2022-10-31 | Glycom As | Composición sintética y método para modular la función cerebral y la conducta |
| CN108289492A (zh) * | 2015-12-15 | 2018-07-17 | 雀巢产品技术援助有限公司 | Hmo的混合物 |
| CN109715169A (zh) | 2016-07-28 | 2019-05-03 | 方塔拉合作集团有限公司 | 乳制品和工艺 |
| EP3641566A1 (en) | 2017-06-21 | 2020-04-29 | Abbott Laboratories | Methods for increasing growth of beneficial bacteria in the gastrointestinal tract |
| BR112020010843A2 (pt) * | 2017-11-30 | 2020-11-10 | Glycom A/S | oligossacarídeos do leite humano e composições sintéticas desses para modulação da microbiota |
| EP3981256A4 (en) * | 2019-06-05 | 2023-01-25 | Morinaga Milk Industry Co., Ltd. | COMPOSITION |
| JP7474596B2 (ja) * | 2020-01-20 | 2024-04-25 | 森永乳業株式会社 | 新規ビフィドバクテリウム属細菌、および当該細菌を含む組成物、並びに当該細菌の増殖促進用の組成物 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5260280A (en) | 1989-02-07 | 1993-11-09 | Snow Brand Milk Products Co., Ltd. | Bacterial toxin neutralizer |
| DE60127533D1 (de) * | 2000-02-17 | 2007-05-10 | Wyeth Corp | Prebiotische substanzen enthaltende ernährungszusammensetzungen |
| EP1257195A2 (en) * | 2000-02-18 | 2002-11-20 | Argose, Inc. | Multivariate analysis of green to ultraviolet spectra of cell and tissue samples |
| US6913778B2 (en) | 2001-12-21 | 2005-07-05 | Wyeth | Infant formula compositions comprising increased amounts of alpha-lactalbumin |
| US7867541B2 (en) | 2003-04-14 | 2011-01-11 | Mead Johnson Nutrition Company | Compositions and methods of formulation for enteral formulas containing sialic acid |
| PL1638416T3 (pl) * | 2003-06-23 | 2013-09-30 | Nestec Sa | Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej |
| WO2005055944A2 (en) | 2003-12-05 | 2005-06-23 | Cincinnati Children's Hospital Medical Center | Oligosaccharide compositions and use thereof in the treatment of infection |
| EA017195B1 (ru) † | 2005-11-04 | 2012-10-30 | Арла Фудз Амба | Концентрат, полученный из молочного продукта, обогащенный природно встречающейся сиалиллактозой, и способ его получения |
| WO2007114683A1 (en) | 2006-03-30 | 2007-10-11 | N.V. Nutricia | Milk oligosaccharides for stimulating the immune system |
| EP2060257A1 (en) * | 2007-11-08 | 2009-05-20 | Nestec S.A. | Prevention and treatment of secondary infections following viral infection |
| EP2072052A1 (en) † | 2007-12-17 | 2009-06-24 | Nestec S.A. | Prevention of opportunistic infections in immune-compromised subjects |
| NL2001377C2 (nl) | 2008-03-14 | 2009-09-15 | Friesland Brands Bv | Werkwijze voor het isoleren van siaalzuur bevattende oligosachariden, alsmede de hiermee verkrijgbare siaalzuur bevattende oligosachariden bevatttende samenstellingen. |
| MX2012001362A (es) * | 2009-07-31 | 2012-02-22 | Nestec Sa | Composicion nutricional para lactantes o mascotas alimentados con leche maternal con probioticos y nutrientes seleccionados. |
| NL2004200C2 (en) * | 2010-02-05 | 2011-08-08 | Friesland Brands Bv | Use of sialyl oligosaccharides in weight management. |
| EP2563165A1 (en) * | 2010-04-27 | 2013-03-06 | N.V. Nutricia | Use of 6'-sialyl lactose in infant and toddler nutrition |
| CN103763940B (zh) * | 2010-12-31 | 2015-10-14 | 雅培制药有限公司 | 促进有益微生物群生长的益生菌和人乳寡糖的合益素组合 |
| BR112013020108A2 (pt) | 2011-02-10 | 2017-06-13 | Nestec Sa | modulação do crescimento de bifidobactérias usando uma combinação de oligossacarídeos encontrados no leite de ser humano |
-
2012
- 2012-02-03 BR BR112013020108A patent/BR112013020108A2/pt not_active Application Discontinuation
- 2012-02-03 RU RU2013141449/13A patent/RU2586928C2/ru active
- 2012-02-03 US US13/984,362 patent/US20140371173A1/en not_active Abandoned
- 2012-02-03 CA CA2825697A patent/CA2825697A1/en not_active Abandoned
- 2012-02-03 MX MX2014008513A patent/MX362129B/es unknown
- 2012-02-03 EP EP12707135.5A patent/EP2672844B2/en active Active
- 2012-02-03 EP EP14177597.3A patent/EP2792252B1/en active Active
- 2012-02-03 WO PCT/IB2012/050511 patent/WO2012107865A2/en active Application Filing
- 2012-02-03 MY MYPI2013701285A patent/MY161034A/en unknown
- 2012-02-03 AU AU2012215042A patent/AU2012215042B2/en active Active
- 2012-02-03 SG SG2013056064A patent/SG192095A1/en unknown
- 2012-02-03 ES ES14177597.3T patent/ES2692533T3/es active Active
- 2012-02-03 CN CN2012800083041A patent/CN103347405A/zh active Pending
- 2012-02-03 MX MX2013009087A patent/MX345413B/es active IP Right Grant
- 2012-02-03 PT PT127071355T patent/PT2672844E/pt unknown
- 2012-02-03 PL PL12707135T patent/PL2672844T3/pl unknown
- 2012-02-03 ES ES12707135T patent/ES2527200T5/es active Active
- 2012-02-03 CN CN201410384571.XA patent/CN104126749A/zh active Pending
- 2012-02-08 TW TW101104099A patent/TW201244640A/zh unknown
- 2012-02-09 US US13/369,619 patent/US20120208782A1/en not_active Abandoned
-
2013
- 2013-07-15 IL IL227487A patent/IL227487A/en not_active IP Right Cessation
- 2013-08-01 CL CL2013002210A patent/CL2013002210A1/es unknown
- 2013-09-09 ZA ZA2013/06751A patent/ZA201306751B/en unknown
-
2015
- 2015-01-26 US US14/604,951 patent/US20150141367A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2672844B1 (en) | 2014-11-19 |
| ES2692533T3 (es) | 2018-12-04 |
| EP2672844B2 (en) | 2022-10-05 |
| EP2792252A3 (en) | 2015-03-25 |
| ZA201306751B (en) | 2015-05-27 |
| TW201244640A (en) | 2012-11-16 |
| IL227487A (en) | 2015-10-29 |
| EP2792252A2 (en) | 2014-10-22 |
| CN103347405A (zh) | 2013-10-09 |
| US20150141367A1 (en) | 2015-05-21 |
| SG192095A1 (en) | 2013-08-30 |
| MX362129B (es) | 2019-01-07 |
| ES2527200T5 (es) | 2022-12-29 |
| ES2527200T3 (es) | 2015-01-21 |
| AU2012215042B2 (en) | 2016-01-14 |
| US20120208782A1 (en) | 2012-08-16 |
| CA2825697A1 (en) | 2012-08-16 |
| WO2012107865A2 (en) | 2012-08-16 |
| US20140371173A1 (en) | 2014-12-18 |
| EP2672844A2 (en) | 2013-12-18 |
| WO2012107865A3 (en) | 2012-11-01 |
| PT2672844E (pt) | 2015-02-04 |
| IL227487A0 (en) | 2013-09-30 |
| EP2792252B1 (en) | 2018-09-12 |
| RU2013141449A (ru) | 2015-03-20 |
| MY161034A (en) | 2017-04-14 |
| MX2013009087A (es) | 2013-09-13 |
| PL2672844T3 (pl) | 2015-04-30 |
| RU2586928C2 (ru) | 2016-06-10 |
| CN104126749A (zh) | 2014-11-05 |
| MX345413B (es) | 2017-01-27 |
| BR112013020108A2 (pt) | 2017-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2013002210A1 (es) | Formulación prebiótica para consumo humano que comprende 2´-fucosilactosa, 3´-sialilactosa y 6´-sialilactosa, en que la cantidad en peso de 3´-sialilactosa es al menos igual de elevada que la cantidad de 2´-fucosilactosa; y método para modular o estimular la proliferación de bifidobacterias en el intestino humano. | |
| EA201500535A1 (ru) | Применение akkermansia muciniphila для лечения метаболических расстройств, увеличения расхода энергии и насыщения, снижения веса, композиция, фармацевтическая композиция, косметическая композиция и лекарственное средство | |
| GT201300243A (es) | Derivados de ácido 3-fenilpropiónico ramificados y su uso | |
| BR112015003332A2 (pt) | composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente | |
| BR112015003398A2 (pt) | composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente | |
| HN2011002406A (es) | 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso | |
| BR112012004806B8 (pt) | composições imunogênicas que incluem moduladores da atividade de tlr, método para aumento da eficácia da referida composição e uso | |
| BR112014010186A2 (pt) | formulação farmacêutica estável, kit, composição farmacêutica, método para preparar uma formulação farmacêutica, e, método para tratar um humano ou animal | |
| BR112013022927A2 (pt) | composição, métodos para substituir ou suplementar ou modificar uma microbiota do cólon de um sujeito, e para tratar um sujeito, e, uso de uma composição | |
| ECSP11011278A (es) | Composición farmacéutica que comprende derivados de glucopiranosil difenilmetano, forma farmacéutica de la misma, procedimiento para su preparación y usos de la misma para el control glucémico mejorado en un paciente. | |
| ECSP13012379A (es) | Pirimidinas y triazinas condensadas y su uso | |
| CR20120596A (es) | 5-fluoro-1h-pirazolopiridinas sustituidas y su uso | |
| BR112014016810A2 (pt) | composições e métodos para tratamento de distúrbios metabólicos | |
| CL2014001587A1 (es) | Combinacion farmaceutica, composicion farmaceutica o kit farmaceutico que comprenden un inhibidor de dpp-4 y un analogo de glp-1; metodo para tratar y/o prevenir la obesidad o el sobrepesoo para reducir el peso corporal en un paciente humano. | |
| ECSP13012668A (es) | Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso | |
| UY31228A1 (es) | Ariloxazoles sustituidos y su uso | |
| CO2018002394A2 (es) | Método para la inhibición de la absorción de lípidos y/o la promoción de excreción de lípidos usando d-psicosa | |
| BR112014006220A2 (pt) | composições de galacto-ramnogalacturonato para o tratamento de esteatohepatite não alcoólica e de doença de gordura no fígado não alcoólica | |
| BR112012029746A2 (pt) | composição para tratamento da pele, método para fornecer um efeito microbicida para pele e uso de uma combinação | |
| BR112012020719A2 (pt) | formulação herbicida método de tratamento de plantas com herbicida método de aumento da eficácia de uma formulação herbicida, e, uso de uma composição | |
| BR112014003640A2 (pt) | métodos para perda de peso e composições cetogênicas | |
| CL2014000050A1 (es) | Composicion farmaceutica en forma de solucion que comprende apomorfina, un codisolvente micible en agua, un antioxidante y agua, en la que el ph es superior a 4; procedimiento para fabricarla; y su uso como solucion inyectable en el tratamiento de la enfermedad de parkinson. | |
| BR112013001297A2 (pt) | composições farmacêuticas e respectivo uso e método de tratamento de doença ou condição respiratória | |
| BR112013026661A2 (pt) | método de entrega de vacina | |
| CL2014002845A1 (es) | Compuestos derivados de pirazol inhibidores de sglt1; metodo para tratar la diabetes; composicion farmaceutica; uso del compuesto para el tratamiento de la diabetes tipo 1 y tipo 2. |